Name | Recombinant Human Semaphorin 6A Fc Chimera Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 1146-S6 |
Category | Protein |
Prices | $329.00 |
Sizes | 25 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Human Semaphorin 6A (Gly19-Thr649) Accession # Q9H2E6 DIEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Bioactivity | Measured by its ability to inhibit the proliferation of HUVEC human umbilical vein endothelial cells. Moriya, J. et al . (2010) Circ. Res. 106 :391. The ED 50 for this effect is 0.4-2.4 μg/mL. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | Q9H2E6 |
Gene | SEMA6A |
Sequence | Gly19 |
Supplier Page | Shop |
Tian X, Yan H, Li J, Wu S, Wang J, Fan L. Int J Mol Sci. 2017 Jan 13;18(1). pii: E148.
Ebert AM, Childs SJ, Hehr CL, Cechmanek PB, McFarlane S. Development. 2014 Jun;141(12):2473-82.
Segarra M, Ohnuki H, Maric D, Salvucci O, Hou X, Kumar A, Li X, Tosato G. Blood. 2012 Nov 8;120(19):4104-15.
Tran-Van H, Avota E, Bortlein C, Mueller N, Schneider-Schaulies S. Eur J Immunol. 2011 Jan;41(1):151-63.
Renaud J, Kerjan G, Sumita I, Zagar Y, Georget V, Kim D, Fouquet C, Suda K, Sanbo M, Suto F, Ackerman SL, Mitchell KJ, Fujisawa H, Chedotal A. Nat Neurosci. 2008 Apr;11(4):440-9.